Therefore, 34 μM and 25 μM Ralo were administered to A172 cells, whereas 32 μM and 15 μM Ralo were administered to U87 cells to observe the effect of Ralo on PKN1 expression and proliferation, invasion, and apoptosis of GBM cells. This evidence concerns the gene PKN1 and glioblastoma.